echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Eur Heart J: The dietary supplement tridecylglycerol significantly resolves atherosclerosis

    Eur Heart J: The dietary supplement tridecylglycerol significantly resolves atherosclerosis

    • Last Update: 2023-02-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    When we were young, our parents told us to eat vitamins so that we could grow big and strong
    .
    Now, in a new study, researchers from Osaka University in Japan have found that a dietary supplement can greatly reverse the signs of heart disease in a subset of
    patients 。 The results of the study were published online on December 30, 2022 in the journal European Heart Journal under the title "Remarkable regression of diffuse coronary atherosclerosis in patients with triglyceride deposit cardiomyovasculopathy

    Coronary artery disease (CAD), which involves narrowing or even closing the arteries of the heart and often leading to heart attacks, is one of the leading causes of
    death worldwide.
    Despite the existence of treatments such as cholesterol-lowering drugs and drug-eluting stents, deaths from the disease are still common, and some patients appear to be resistant to treatment
    .

    Dr.
    Ken-ichi Hirano of Osaka University, corresponding author of the paper, said, "Almost 15 years ago, we discovered a new type of CAD called triglyceride deposition cardiovascular disease (TGCV), in which the coronary arteries are blocked
    by triglyceride deposits produced by defects in the intracellular breakdown of triglycerides in vascular smooth muscle cells.
    This mechanism distinguishes TGCV from classic cholesterol-induced atherosclerosis and explains those patients
    who are resistant to standard therapies for CAD.

    Scientists have developed diagnostic criteria for TGCV and shown that the disease is particularly prevalent
    in people with diabetes and those who have undergone hemodialysis.
    However, despite the ability to diagnose the disease, effective treatment for these patients remains far away
    .

    Hirano said, "Today, we report significant resolution
    of diffuse coronary atherosclerosis in two TGCV patients.
    Both patients had refractory chest pain and diabetes prior to being diagnosed with TGCV, followed by dietary intake of tricaprin, which led to symptom relief
    .

    Tridecylglycerol is a commercially available food supplement that promotes the breakdown
    of lipids in cardiomyocytes.
    In addition to relieving the painful symptoms of these patients, tridecylglycerol also significantly reduces the accumulation of triglycerides in the blood vessels of the heart
    .

    TGCV is an emerging cardiovascular disease characterized by defects in intracellular lipolysis caused by diffuse stenosis of coronary atherosclerosis and triglyceride (TG) deposition
    .
    Image from European Heart Journal, 2022, doi:10.
    1093/eurheartj/ehac762
    .

    "While atherosclerotic resolution after a decrease in serum lipid levels is well described, this is the first report of atherosclerotic resolution due to increased triglyceride lipolysis and is therefore a conceptually novel treatment
    for coronary atherosclerosis," Hirano said.

    Given that not all patients respond to current CAD treatments, the results of this new study pave the way
    for a multi-faceted CAD treatment approach.
    The remarkable results achieved through the use of an off-the-shelf dietary supplement offer hope
    for those patients who will continue to suffer the debilitating effects of this disease.
    (Biovalley Bioon.
    com)

    Resources:

    Ken-ichi Hirano et al.
     Remarkable regression of diffuse coronary atherosclerosis in patients with triglyceride deposit cardiomyovasculopathy.
    European Heart Journal, 2022, doi:10.
    1093/eurheartj/ehac762.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.